Lipoprotein-associated phospholipase A₂: a target directed at the atherosclerotic plaque

Bibliography

• VAUGHAN CJ, GOTTO AM, BASSON CT: The evolving role of statins in the management of atherosclerosis. I Am. Coll Cordial. (2000) 35:1–10.
   PubMed Web of Science ®Google Scholar
• CHANG MY, POTTER-PERIGO S, WIGHT TN, CHAIT A: Oxidized LDL bind to nonproteoglycan components of smooth muscle extracellular matrices. j. Lipid Res. (2001) 42:824–833.
   Google Scholar
• KITA K, KUME N, MINAMI C et al.: Role of oxidised LDL in atherosclerosis. Ann. NY Acad. Sci. (2001) 947:199–206.
   PubMed Web of Science ®Google Scholar
• PENTIKAINEN MO, OKSJOKI R, OORNI K, KOVANEN PT: Lipoprotein lipase in the arterial wall: linking LDL to the arterial extracellular matrix and much more. Arterioscler. Thromb. Vasc. Biol. (2002) 22:211–217.
   Google Scholar
• ZAMAN AG, HELFT G, WORTHLEY SG, BADIMON JJ: The role of plaque rupture and thrombosis in coronary artery disease. Atherosclerosis (2000) 149:251–266.
   PubMed Web of Science ®Google Scholar
• ROSS R: Atherosclerosis - an inflammatory disease. N Engl. J Med. (1999) 340:115–126.
   PubMed Web of Science ®Google Scholar
• ASANO K, OKAMOTO S, FUKUNAGA K etal.: Cellular source(s) of platelet-activating-factor acetylhydrolase activity in plasma. Biochem. Biophys. Res. Commun. (1999) 261:511–514.
   Google Scholar
• NAKAJIMA K, MURIKAMI M, YANOSHITA R et al: Activated mast cells release extracellular type platelet-activating factor acetylhydrolase that contributes to autocrine inactivation of platelet-activating factor. Bia. Chem. (1997) 272:19708–19713.
   Google Scholar
• HAKKINEN T, LUOMA JS, HILTUNEN MO et al.: Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. (1999) 19:2909–2917.
   PubMed Web of Science ®Google Scholar
• MACPHEE CH, MOORES KE, BOYD HF et al.: Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor. Biochem. J. (1999) 338:479–487.
   PubMed Web of Science ®Google Scholar
• CARPENTER KLH, DENNIS IF, CHALLIS IR et al: Inhibition of lipoprotein-associated phospholipase A(2) diminishes the death-inducing effects of oxidised LDL on human monocyte-macrophages. FEBS Lett. (2001) 505:357–363.
   Google Scholar
• RIKITAKE Y, HIRATA K, KAWASHIMA S etal.: Signaling mechanism underlying COX-2 induction by lysophosphatidylcholine. Biochem. Biophys. Res. Commun. (2001) 281:1291–1297.
   Google Scholar
• WATANABE T, PAKALA R, KOBA S, KATAGIRI T, BENEDICT CR: Lysophosphatidylcholine and reactive oxygen species mediate the synergistic effect of mildly oxidized LDL with serotonin on vascular smooth muscle cell proliferation. Circulation (2001) 103:1440–1445.
   PubMed Web of Science ®Google Scholar
• EOUE N, TAKESHITA S, GAO DY etal.:Lysophosphatidylcholine increases the secretion of matrix metalloproteinase 2 through the activation of NADH/NADPH oxidase in cultured aortic endothelial cells. Atherosclerosis (2001) 155:45–52.
   Google Scholar
• BOURDON E, LOREAU N, DAVIGNON J, BERNIER L, BLACHE D: Involvement of oxysterols and lysophosphatidylcholine in the oxidized LDL-induced impairment of serum albumin synthesis by HEPG2 cells. Arterioscler. Thromb. Vase. Biol. (2000) 20:2643–2650.
   Google Scholar
• DICHTL W, STIKO A, ERIKSSON P et al: Oxidized LDL and lysophosphatidylcholine stimulate plasminogen activator inhibitor-I expression in vascular smooth muscle cells. Arteriosc/er. Thromb. Vase. Bid. (1999) 19:3025–3032.
   PubMed Web of Science ®Google Scholar
• KITA T, KUME N, ISHII K, HORIUCHI H, ARAI H, YOKODE M: Oxidized LDL and expression of monocyte adhesion molecules. Diabetes Res.Clin. Pict. (1999) 45:123–126.
   Google Scholar
• RIKITAKE Y, KAWASHIMA S, YAMASHITA T etal.: Lysophosphatidylcholine inhibits endothelial cell migration and proliferation via inhibition of the extracellular signal-related kinase pathway. Arterioscler. Thromb. Vasc. Biol. (2000) 20:1006–1012.
   Google Scholar
• KUGIYAMA K, SUGIYAMA S, OGATA N etal.: Burst prodution of superoxide anion in human endothelial cells by lysophosphatidylcholine. Atherosclerosis (1999) 143:201–204.
   Google Scholar
• TEW DG, SOUTHAN C, RICE SQJ et al.: Purification, properties, sequencing, and cloning of a lipoprotein- associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins. Arterioscler. Thromb. Vasc. Biol. (1996) 16:591–599.
   PubMedGoogle Scholar
• BOYD HF, FLYNN ST, HICKEY DMB et al.: 2-(Alkylthio)pyrimidin-4-ones as novel, reversible inhibitors of lipoprotein-associated phospholipase A(2). Bioarg. Med. Chem. Lett. (2000) 10:395–398.
   Google Scholar
• BOYD HF, FELL SCM, FLYNN ST et al: N-1 substituted pyrimidin-4-ones: Novel, orally active inhibitors of lipoprotein-associated phospholipase A(2). Bioarg. Med. Chem. Lett. (2000) 10:2557–2561.
   Google Scholar
• BENSON GM, GRIMSDITCH DC, MILLINER KJ etal.: Anti-atherosclerotic effect of SB-244323, a lipoprotein-associated phospholipase A2 inhibitor in WHHL rabbits. Atherosclerosis (2000) 151:166 (Abstract).
   Google Scholar
• CASLAKE MJ, PACKARD CJ, SUCKLING KE, HOLMES SD, CHAMBERLAIN P, MACPHEE CH: Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease. Atherosclerosis (2000) 150:413–419.
   PubMed Web of Science ®Google Scholar
• PACKARD CJ, O'REILLY DSJ, CASLAKE MJ etal: Lipoprotein-associated phospholipase A(2) as an independent predictor of coronary heart disease. N Engl. J Med. (2000) 343:1148–1155.
   PubMed Web of Science ®Google Scholar
• BLAKE GJ, DADA N, FOX JC, MANSON JE, RIDKER PM: A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in women. I Am. Coll. Cardiol. (2001) 38:1302–1306.
   PubMed Web of Science ®Google Scholar
• DADA N, KIM NW WOLFERT RL: Lp-PLA2: an emerging biomarker of coronary heart disease. Expert Rev Mal Diagn (2002) 2:17–22.
   PubMedGoogle Scholar
• SIX DA, DENNIS EA: The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim. Biophys. Acta Mal Cell Biol. Lipids (2000) 1488:1–19.
   PubMed Web of Science ®Google Scholar
• HURT-CAMEJO E, CAMEJO G, PEILOT H, OORNI K, KOVANEN P: Phospholipase A(2) in vascular disease. Circ. Res. (2001) 89:298–304.
   PubMed Web of Science ®Google Scholar
• HURT-CAMEJO E, CAMEJO G, SARTIPY P: Phospholipase A(2) and small, dense low-density lipoprotein. Curr. Opin. Lipidol. (2000) 11:465–471.
   Google Scholar
• PRESCOTT SM, ZIMMERMAN GA, STAFFORINI DM, MCINTYRE TM: Platelet-activating factor and related lipid mediators. Ann. Rev. Biochem. (2000) 69:419–445.
   PubMed Web of Science ®Google Scholar
• KULLER LH: Clinical trials: surrogate endpoints or hard endpoints? Am. J. Cardiol (2001) 88:59E–61E.
   Google Scholar
• RIDKER PM, STAMPFER MJ, RIFAI N: Novel risk factors for systemic atherosclerosis — a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA (2001) 285:2481–2485.
   PubMed Web of Science ®Google Scholar
• RIDKER PM: High-sensitivity C-reactive protein — potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation (2001) 103:1813–1818.
   Google Scholar
• RIFAI N, RIDKER PM: High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem. (2001) 47:403–411.
   PubMed Web of Science ®Google Scholar
• RIDKER PM, BURING JE, RIFAI N: Soluble P-selectin and the risk of future cardiovascular events. Circulation (2001) 103:491–495.
   PubMed Web of Science ®Google Scholar
• FAYAD ZA, FUSTER V: The human high-risk plaque and its detection by magnetic resonance imaging. Am. J. Cardiol (2001) 88:42E–45E.
   Google Scholar
• FRANK H: Characterization of atherosclerotic plaque by magnetic resonance imaging. Am. Heart J. (2001) 141:S45–S48.
   Google Scholar
• O'ROURKE RA, BRUNDAGE BH, FROELICHER VF etal.: American College of Cardiology/American Heart Association expert consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J. Am. Coll. Cardiol (2000) 36:326–340.
   Google Scholar